In a filing, Alaunos Therapeutics Inc. revealed its Chief Executive Officer Boyle Kevin S. Sr. unloaded Company’s shares for reported $9542.0 on Sep 01. In the deal valued at $0.14 per share,68,014 shares were sold. As a result of this transaction, Boyle Kevin S. Sr. now holds 798,236 shares worth roughly $ 0.1 million.
Then, Vieser Jaime bought 1,250,000 shares, generating $812,500 in total proceeds. Upon buying the shares at $0.65, the Director now owns 1,250,000 shares.
Before that, Postma Robert W bought 750,000 shares. Alaunos Therapeutics Inc. shares valued at $487,500 were divested by the Director at a price of $0.65 per share. As a result of the transaction, Postma Robert W now holds 5,000,000 shares, worth roughly $0.65 million.
PT values the company’s stock at a premium of 95.67 to its Tuesday closing price.
Price Performance Review of TCRT
On Tuesday, Alaunos Therapeutics Inc. [NASDAQ:TCRT] saw its stock fall -8.90% to $0.13. On the same session, the stock had its day’s lowest price of $0.1301, but rose to a high of $0.143. Over the last five days, the stock has gained 3.15%. Alaunos Therapeutics Inc. shares have fallen nearly -79.82% since the year began. Nevertheless, the stocks have fallen -95.65% over the past one year. While a 52-week high of $4.01 was reached on 01/17/23, a 52-week low of $0.12 was recorded on 08/22/23. SMA at 50 days reached $0.3620, while 200 days put it at $0.5521. A total of 1.17 million shares were traded, compared to the trading of 1.44 million shares in the previous session.
Levels Of Support And Resistance For TCRT Stock
The 24-hour chart illustrates a support level at 0.1264, which if violated will result in even more drops to 0.1218. On the upside, there is a resistance level at 0.1393. A further resistance level may holdings at 0.1476. The Relative Strength Index (RSI) on the 14-day chart is 27.19, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.0006, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 88.76%. Stochastics %K at 19.95% indicates the stock is a buying.
How much short interest is there in Alaunos Therapeutics Inc.?
A steep rise in short interest was recorded in Alaunos Therapeutics Inc. stocks on Aug 14, 2023, dropping by -0.11 million shares to a total of 25.71 million shares. Yahoo Finance data shows the prior-month short interest on Jul 13, 2023 was 25.82 million shares. There was a decline of -0.43%, which implies that there is a negative sentiment for the stock. In spite of short shares comprising just 11.17% of the overall stock float, the days-to-cover ratio (short ratio) fell to 17.81.
According to FactSet, Alaunos Therapeutics Inc.’s share price will average $7.50 in the next year, based on opinions of analysts polled by the firm. This is up nearly 5257.14 percent from its previous closing price of $0.14. Analysts expect Alaunos Therapeutics Inc. stock to reach the higher price of $7.50, while the lowest price estimate is $7.50. However, 2 analysts have rated TCRT stock as a Hold in their predictions for 2023.